Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors
Open Access
- 15 October 2002
- journal article
- Published by American Society of Hematology in Blood
- Vol. 100 (8) , 2932-2940
Abstract
Idiopathic myelofibrosis (IMF) is a chronic myeloproliferative disorder characterized by megakaryocyte hyperplasia and bone marrow fibrosis. Biologically, an autonomous megakaryocyte growth and differentiation is noticed, which contributes to the megakaryocyte accumulation. To better understand the molecular mechanisms involved in this spontaneous growth, we searched for genes differentially expressed between normal megakaryocytes requiring cytokines to grow and IMF spontaneously proliferating megakaryocytes. Using a differential display technique, we found that the immunophilin FKBP51 was 2 to 8 times overexpressed in megakaryocytes derived from patients9 CD34+ cells in comparison to normal megakaryocytes. Overexpression was moderate and confirmed in 8 of 10 patients, both at the mRNA and protein levels. Overexpression of FKBP51 in a UT-7/Mpl cell line and in normal CD34+ cells induced a resistance to apoptosis mediated by cytokine deprivation with no effect on proliferation. FKBP51 interacts with both calcineurin and heat shock protein (HSP)70/HSP90. However, a mutant FKBP51 deleted in the HSP70/HSP90 binding site kept the antiapoptotic effect, suggesting that the calcineurin pathway was responsible for the FKBP51 effect. Overexpression of FKBP51 in UT-7/Mpl cells induced a marked inhibition of calcineurin activity. Pharmacologic inhibition of calcineurin by cyclosporin A mimicked the effect of FKBP51. The data support the conclusion that FKBP51 inhibits apoptosis through a calcineurin-dependent pathway. In conclusion, FKBP51 is overexpressed in IMF megakaryocytes and this overexpression could be, in part, responsible for the megakaryocytic accumulation observed in this disorder by regulating their apoptotic program.Keywords
This publication has 57 references indexed in Scilit:
- Elevated vascular endothelial growth factor (VEGF) serum levels in idiopathic myelofibrosisLeukemia, 2001
- Functional analysis of the hsp90-associated human peptidyl prolyl Cis/Trans isomerases FKBP51, FKBP52 and cyp40 1 1Edited by R. HuberJournal of Molecular Biology, 2001
- Myelofibrosis with Myeloid MetaplasiaNew England Journal of Medicine, 2000
- The role of transforming growth factor‐β in PEG‐rHuMGDF‐induced reversible myelofibrosis in ratsBritish Journal of Haematology, 1997
- Allogeneic bone marrow transplantation for agnogenic myeloid metaplasiaBritish Journal of Haematology, 1997
- Cyclosporin A interferes with the inducible degradation of NF‐xB inhibitors, but not with the processing of p105/NF‐xB1 in T cellsEuropean Journal of Immunology, 1997
- Tissue Distribution and Abundance of Human FKBP51, an FK506-Binding Protein That Can Mediate Calcineurin InhibitionBiochemical and Biophysical Research Communications, 1997
- Primary myelofibrosis: A detailed statistical analysis of the clinicopathological variables influencing survivalAnnals of Hematology, 1994
- Calcineurin Activates Transcription from the GM-CSF Promoter in Synergy with Either Protein Kinase C or NF-κB/AP-1 in T-CellsBiochemical and Biophysical Research Communications, 1994
- Detection of Platelet-Specific Protein mRNAs in Different Megakaryoblasts Using the Reverse Transcriptase Polymerase Chain ReactionLeukemia & Lymphoma, 1992